Detailed Information on Publication Record
2013
Immobilization of Cytochrome P450 2C9 on Magnetic Nanoparticles
ŘEMÍNEK, Roman, Jan SCHEJBAL, Lukáš ZEMAN, Marta ZEISBERGEROVÁ, Zdeněk GLATZ et. al.Basic information
Original name
Immobilization of Cytochrome P450 2C9 on Magnetic Nanoparticles
Name in Czech
Imobilizace cytochromu P450 2C9 na magnetických nanočásticích
Authors
Edition
20th International Symposium on Electro- and Liquid Phase- Separation Techniques - ITP 2013, 2013
Other information
Language
English
Type of outcome
Konferenční abstrakt
Field of Study
10600 1.6 Biological sciences
Country of publisher
Spain
Confidentiality degree
není předmětem státního či obchodního tajemství
Organization unit
Faculty of Science
Keywords (in Czech)
Capillary electrophoresis, Cytochrome P450 2C9, IMER, Magnetic nanoparticles
Keywords in English
kapilární elektroforéza, cytochrom P450 2C9, IMER, magnetické nanočástice
Tags
Tags
International impact, Reviewed
Změněno: 30/1/2014 10:04, prof. RNDr. Zdeněk Glatz, CSc.
V originále
Studies of the affinity of a drug candidate compounds to drug-metabolizing enzymes, e.g. cytochromes P450, and the investigation of potential drug-drug interactions constitute a routine part of a new drug development processes. Due to the extensive numbers of tested candidates, there is ongoing trend towards the rationalization and hastening of screening assays. Enzyme immobilization represents a useful approach in this field because of repetitive use of a single batch of enzymes and simplification of sequential analyses by providing protein-free samples. Moreover, immobilized enzymes typically have greater thermal and operational stability compared to their soluble forms. The goal of this study was to develop method for immobilization of clinically important cytochrome P450 2C9 isoform (CYP2C9) on magnetic nanoparticles SiMAG. In addition to above mentioned list of advantages, utilization of magnetic support enables easy enzyme positioning inside reaction vessel and fast removal of enzyme and thus reaction termination using magnet. Parameters of immobilization procedure such as attachment scheme, concentration of support surface activators, composition, concentration and pH of immobilization buffer, attachment time and temperature and concentration of immobilized CYP2C9 were optimized with respect to its activity and stability. After the method optimization was complete, there was experimentally proved that immobilized CYP2C9 can be repetitively used for 12 hours without considerable loss of activity. Performed kinetic study of CYP2C9 reaction with diclofenac used as a probe substrate proved that the binding have no negative effect on enzyme activity. Obtained apparent values of Michaelis constant (Km = 2.57 +- 0.15 uM) and Hill coefficient (n = 1.13 +- 0.08) were in a good agreement with literature data determined using homogeneous assays [1–3]. What is more, obtained apparent value of maximal reaction velocity (Vmax = 28.26 +- 0.72 nmol/min/nmol) was significantly higher than it was reported in the reference. In the next study, presented system will be used for construction of in-capillary reactor enabling screenings of drug metabolism by means of on-line capillary electrophoresis. This work was supported by grant No. P206/10/0057 from the Grant Agency of the Czech Republic and by project CZ.1.07/2.3.00/20.0182 from the European Regional Development Fund. [1] R.L. Walsky, R.S. Obach, Drug Metab. Dispos. 32 (2004) 647-660. [2] A. Di Marco, I. Marcucci, A. Chaudhary, M. Taliani, R. Laufer, Drug. Metab. Dispos. 33 (2005) 359-364. [3] J. Konečný, J. Juřica, J. Tomandl, Z. Glatz, Electrophoresis 28 (2007) 1229-1234.
In Czech
Byla zavedena metoda pro imobilizaci terapeuticky významného cytochromu P450 2C9 na magnetických nanočásticích SiMAG-Carboxyl. Provedená kinetická studie s modelovým substrátem diklofenakem prokázala, že připojení enzymu k magnetickému nosiči nemá negativní vliv na aktivitu enzymu. Systém je tak připraven pro konstrukci kapilárního reaktoru.
Links
| CZ.1.07/2.3.00/20.0182, interní kód MU (CEP code: EE2.3.20.0182) |
| ||
| GAP206/10/0057, research and development project |
|